Drug Therapy, Combination

Experimental Therapeutics
Drug Therapy of Experimental Tuberculosis (TB): Improved Outcome by Combining SQ109, a New Diamine Antibiotic, with Existing TB Drugs
Boris V. Nikonenko, Marina Protopopova, Rowena Samala, Leo Einck, Carol A. Nacy
Clinical Therapeutics
Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections
Mark J. DiNubile, Joseph W. Chow, Vilas Satishchandran, Adam Polis, Mary R. Motyl, Murray A. Abramson, Hedy Teppler
Clinical Therapeutics
Amoxicillin-Clavulanate Therapy Increases Childhood Nasal Colonization by Methicillin-Susceptible Staphylococcus aureus Strains Producing High Levels of Penicillinase
Didier Guillemot, Stephane Bonacorsi, John S. Blanchard, Philippe Weber, Sylvie Simon, Bruno Guesnon, Edouard Bingen, Claude Carbon
Pharmacology
Novel Approach to Characterization of Combined Pharmacodynamic Effects of Antimicrobial Agents
Vincent H. Tam, Amy N. Schilling, Russell E. Lewis, David A. Melnick, Adam N. Boucher
Experimental Therapeutics
In Vitro Killing of Community-Associated Methicillin-Resistant Staphylococcus aureus with Drug Combinations
Samuel A. Shelburne, Daniel M. Musher, Kristina Hulten, Heather Ceasar, Michael Y. Lu, Imran Bhaila, Richard J. Hamill
Experimental Therapeutics
Posaconazole and Amphotericin B Combination Therapy against Cryptococcus neoformans Infection
Francesco Barchiesi, Elisabetta Spreghini, Anna M. Schimizzi, Monia Maracci, Daniele Giannini, Flavia Carle, Giorgio Scalise
Clinical Therapeutics
Double-Blind, Randomized Study of the Efficacy and Safety of Oral Pharmacokinetically Enhanced Amoxicillin-Clavulanate (2,000/125 Milligrams) versus Those of Amoxicillin-Clavulanate (875/125 Milligrams), Both Given Twice Daily for 7 Days, in Treatment of Bacterial Community-Acquired Pneumonia in Adults
T. M. File, H. Lode, H. Kurz, R. Kozak, H. Xie, E. Berkowitz
and the 600 Study Group
Clinical Therapeutics
Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model
Alasdair P. MacGowan, Alan R. Noel, Chris A. Rogers, Karen E. Bowker
Mechanisms of Action: Physiological Effects
Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum
Nina Singh, Asia Obman, Shahid Husain, Sherrie Aspinall, Sue Mietzner, Janet E. Stout
Experimental Therapeutics
Effect of Amoxicillin-Clavulanic Acid on Human Fecal Flora in a Gnotobiotic Mouse Model Assessed with Fluorescence Hybridization Using Group-Specific 16S rRNA Probes in Combination with Flow Cytometry
Marie Claude Barc, François Bourlioux, Lionel Rigottier-Gois, Céline Charrin-Sarnel, Claire Janoir, Hélène Boureau, Joël Doré, Anne Collignon

Pages